Chesapeake Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Chesapeake Capital's VRTX Position: Q3 2026 in Review
Chesapeake Capital opened a new position in Vertex Pharmaceuticals (VRTX) in Q3 2026: 3,793 shares worth $1.98M. The stake represents 1.57% of the portfolio and ranks #29 among its holdings.
1,556 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.
- Chesapeake Capital held 3,793 shares of Vertex Pharmaceuticals worth $1.98M as of Q3 2026.
- Vertex Pharmaceuticals was a new Chesapeake Capital position in Q3 2026.
- Vertex Pharmaceuticals made up 1.57% of Chesapeake Capital's portfolio in Q3 2026, its #29 holding.
- 1,556 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.
Based on Chesapeake Capital's 13F filing for Q3 2026, filed 9 Nov 2026.